Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Latest filing published 25 Aug 2026 for Lyell Immunopharma, Inc., €19k. Read the official filing
Filing timeline
BuySaleGary K. Lee
Insider track record
Disclosed buys
0
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Gary K. Lee: trading record in brief
This profile gathers the share dealings of Gary K. Lee in Lyell Immunopharma, Inc. In total, 9 filings cover trades dated from 9 February 2024 to 21 August 2026.
Every open-market trade on record is a sale: 5 sales worth €57k. Besides market trades, the filings include 4 share grants. Since January 2026: no purchases and 3 sales on the market.
Most recently, on 25 August 2026, the filings show an open-market sale worth €19k in Lyell Immunopharma, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Gary K. Lee
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
1,457 shares@ US$15.54Common StockSEC:0001907345-26-000006:0
131 shares@ US$14.340.0005% mcap4.3% of flowCommon StockSEC:0001907345-26-000004:0
1,671 shares@ US$23.3991.3% of flowCommon StockSEC:0001907345-26-000002:0
4,000 shares0Common StockSEC:0001907345-26-000001:0
138 shares@ US$16.1661.9% of flowCommon StockSEC:0001907345-25-000006:0
8,000 shares0Common StockSEC:0001415889-25-022740:0
131 shares@ US$10.526100.0% of flowCommon StockSEC:0001415889-25-021692:0
112,500 shares0Common StockSEC:0001415889-25-005747:0
40,000 shares0Common StockSEC:0001209191-24-003272:0
9 of 9 declarations
